Risk factors associated with distal catheter migration following ventriculoperitoneal shunt placement
- PMID: 26549674
- PMCID: PMC6262820
- DOI: 10.1016/j.jocn.2015.07.022
Risk factors associated with distal catheter migration following ventriculoperitoneal shunt placement
Abstract
Ventriculoperitoneal (VP) shunt placement is used to treat hydrocephalus. Shunt migration following VP shunt placement has been reported. The risk factors related to this complication have not been previously evaluated to our knowledge. In this retrospective cohort study, we aimed to determine risk factors leading to distal catheter migration and review the literature on the current methods of management and prevention. Adult patients undergoing VP shunt placement from June 2011 to December 2013 at a single institution were identified using electronic health records. The records were reviewed for demographic and procedural information, and subsequent treatment characteristics. The parameters of patients with distal shunt migration were compared to those undergoing new VP shunt placement for the same time period. We identified 137 patients undergoing 157 new VP shunt procedures with an average age of 57.7 ± standard deviation of 18.4 years old. There were 16 distal shunt migrations. Body mass index >30 kg/m(2) and number of previous shunt procedures were found to be independent risk factors for distal catheter migration. Obesity and number of previous shunt procedures were factors for distal catheter migration. Providers and patients should be aware of these possible risk factors prior to VP shunt placement.
Keywords: Distal shunt revision; Shunt complication; Shunt malfunction; Shunt migration; Shunt revision; VP shunt.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Conflicts of Interest/Disclosures
The authors declare that they have no financial or other conflicts of interest in relation to this research and its publication.
Figures
References
-
- Pudenz RH. The surgical treatment of hydrocephalus–an historical review. Surg Neurol 1981;15:15–26. - PubMed
-
- Patwardhan RV, Nanda A. Implanted ventricular shunts in the United States: the billion-dollar-a-year cost of hydrocephalus treatment. Neurosurgery 2005;56:139–44 [discussion 144–5]. - PubMed
-
- Ernst A, Radonic M, Belicza M. The syndrome of long-standing Staphylococcus albus bacteremia, bacterial endocarditis and diffuse membranoproliferative glomerulonephritis complicating ventriculoatrial shunt infection–case report and review of literature. Acta Med Iugosl 1980;34:137–52. - PubMed
-
- Lam CH, Villemure JG. Comparison between ventriculoatrial and ventriculoperitoneal shunting in the adult population. Br J Neurosurg 1997; 11:43–8. - PubMed
-
- Olsen L, Frykberg T. Complications in the treatment of hydrocephalus in children. A comparison of ventriculoatrial and ventriculoperitoneal shunts in a 20-year material. Acta Paediatr Scand 1983;72:385–90. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
